Literature DB >> 28376615

Diselenide-Containing Hyperbranched Polymer with Light-Induced Cytotoxicity.

Chenxing Sun1, Shaobo Ji1, Feng Li1, Huaping Xu1.   

Abstract

A light-induced cytotoxicity system was fabricated using active diselenide/porphyrin-containing hyperbranched polymer aggregates in aqueous solution through emulsification. When the nanoparticles were irradiated with visible light, 1O2 was produced by the porphyrin photosensitizers in the system, which cleaved the diselenide bonds in the polymer chains and disassembled the nanosystem. Interestingly, the oxidized products exhibited cytotoxicity to the MDA-MB 231cell line without using extra anticancer drugs, which endowed the system with potential visible light-induced antitumor activity. In combination with photodynamic therapy, it is greatly anticipated that better anticancer efficacy can be achieved with this system.

Entities:  

Keywords:  chemotherapy; diselenide; hyperbranched polymer; singlet oxygen; stimuli response

Mesh:

Substances:

Year:  2017        PMID: 28376615     DOI: 10.1021/acsami.7b02367

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  12 in total

1.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

2.  Magnetic Hyperbranched Molecular Materials for Treatment of Oily Sewage Containing Polymer in Oilfield Compound Flooding.

Authors:  Sanyuan Qiao; Qingwang Liu; Zhenzhong Fan; Qilei Tong; Li Cai; Yuanfeng Fu
Journal:  Front Chem       Date:  2022-05-18       Impact factor: 5.545

Review 3.  Reactive Oxygen Species Responsive Polymers for Drug Delivery Systems.

Authors:  Fengxiang Gao; Zhengrong Xiong
Journal:  Front Chem       Date:  2021-04-23       Impact factor: 5.221

4.  Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy.

Authors:  Bingjun Sun; Cong Luo; Xuanbo Zhang; Mengran Guo; Mengchi Sun; Han Yu; Qin Chen; Wenqian Yang; Menglin Wang; Shiyi Zuo; Pengyu Chen; Qiming Kan; Haotian Zhang; Yongjun Wang; Zhonggui He; Jin Sun
Journal:  Nat Commun       Date:  2019-07-19       Impact factor: 14.919

5.  Design and Fabrication of Dual Redox Responsive Nanoparticles with Diselenide Linkage Combined Photodynamically to Effectively Enhance Gene Expression.

Authors:  Yan Fang; Xiaojie Lin; Xuechao Jin; Dongjuan Yang; Shan Gao; Kai Shi; Mingshi Yang
Journal:  Int J Nanomedicine       Date:  2020-10-01

6.  The First Selenoanhydride in the Series of Chlorophyll a Derivatives, Its Stability and Photoinduced Cytotoxicity.

Authors:  Viktor Pogorilyy; Anna Plyutinskaya; Nikita Suvorov; Ekaterina Diachkova; Yuriy Vasil'ev; Andrei Pankratov; Andrey Mironov; Mikhail Grin
Journal:  Molecules       Date:  2021-12-01       Impact factor: 4.411

7.  Hyaluronic acid-modified redox-sensitive hybrid nanocomplex loading with siRNA for non-small-cell lung carcinoma therapy.

Authors:  Daoyuan Chen; Peng Zhang; Minghui Li; Congcong Li; Xiaoyan Lu; Yiying Sun; Kaoxiang Sun
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

8.  Folic acid functionalized aggregation-induced emission nanoparticles for tumor cell targeted imaging and photodynamic therapy.

Authors:  Danning Wen; Xueyun Zhang; Lei Ding; Huan Wen; Wen Liu; Chengwu Zhang; Bin Wang; Lihong Li; Haipeng Diao
Journal:  RSC Adv       Date:  2022-02-03       Impact factor: 3.361

9.  Targeted Delivery of Chlorin e6 via Redox Sensitive Diselenide-Containing Micelles for Improved Photodynamic Therapy in Cluster of Differentiation 44-Overexpressing Breast Cancer.

Authors:  Chan Feng; Donglei Zhu; Lv Chen; Yonglin Lu; Jie Liu; Na Yoon Kim; Shujing Liang; Xia Zhang; Yun Lin; Yabin Ma; Chunyan Dong
Journal:  Front Pharmacol       Date:  2019-04-16       Impact factor: 5.810

10.  Programmable Ce6 Delivery via Cyclopamine Based Tumor Microenvironment Modulating Nano-System for Enhanced Photodynamic Therapy in Breast Cancer.

Authors:  Chan Feng; Lv Chen; Yonglin Lu; Jie Liu; Shujing Liang; Yun Lin; Yongyong Li; Chunyan Dong
Journal:  Front Chem       Date:  2019-12-05       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.